QuidelOrtho Corporation (QDEL)
QuidelOrtho Statistics
Share Statistics
QuidelOrtho has 67.45M shares outstanding. The number of shares has increased by 0.71% in one year.
Shares Outstanding | 67.45M |
Shares Change (YoY) | 0.71% |
Shares Change (QoQ) | 0.28% |
Owned by Institutions (%) | 99.99% |
Shares Floating | 66.26M |
Failed to Deliver (FTD) Shares | 10.2K |
FTD / Avg. Volume | 0.99% |
Short Selling Information
The latest short interest is 4.06M, so 6.02% of the outstanding shares have been sold short.
Short Interest | 4.06M |
Short % of Shares Out | 6.02% |
Short % of Float | 8.79% |
Short Ratio (days to cover) | 4.36 |
Valuation Ratios
The PE ratio is -1.46 and the forward PE ratio is 7.67. QuidelOrtho's PEG ratio is 0.
PE Ratio | -1.46 |
Forward PE | 7.67 |
PS Ratio | 1.06 |
Forward PS | 0.6 |
PB Ratio | 0.99 |
P/FCF Ratio | 35.62 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for QuidelOrtho.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.17.
Current Ratio | 1.22 |
Quick Ratio | 0.69 |
Debt / Equity | 0.17 |
Debt / EBITDA | -0.26 |
Debt / FCF | 6.13 |
Interest Coverage | -10.41 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $421.65K |
Profits Per Employee | $-307.12K |
Employee Count | 6,600 |
Asset Turnover | 0.43 |
Inventory Turnover | 2.8 |
Taxes
Income Tax | -79.5M |
Effective Tax Rate | 3.73% |
Stock Price Statistics
The stock price has increased by -34.24% in the last 52 weeks. The beta is 0.43, so QuidelOrtho's price volatility has been higher than the market average.
Beta | 0.43 |
52-Week Price Change | -34.24% |
50-Day Moving Average | 36.06 |
200-Day Moving Average | 39.97 |
Relative Strength Index (RSI) | 27.61 |
Average Volume (20 Days) | 1.03M |
Income Statement
In the last 12 months, QuidelOrtho had revenue of 2.78B and earned -2.03B in profits. Earnings per share was -30.16.
Revenue | 2.78B |
Gross Profit | 1.29B |
Operating Income | -1.96B |
Net Income | -2.03B |
EBITDA | -1.96B |
EBIT | -1.94B |
Earnings Per Share (EPS) | -30.16 |
Balance Sheet
The company has 98.3M in cash and 509M in debt, giving a net cash position of -410.7M.
Cash & Cash Equivalents | 98.3M |
Total Debt | 509M |
Net Cash | -410.7M |
Retained Earnings | 135.8M |
Total Assets | 6.45B |
Working Capital | 220.1M |
Cash Flow
In the last 12 months, operating cash flow was 83M and capital expenditures 0, giving a free cash flow of 83M.
Operating Cash Flow | 83M |
Capital Expenditures | 0 |
Free Cash Flow | 83M |
FCF Per Share | 1.24 |
Margins
Gross margin is 46.23%, with operating and profit margins of -70.46% and -72.84%.
Gross Margin | 46.23% |
Operating Margin | -70.46% |
Pretax Margin | -76.59% |
Profit Margin | -72.84% |
EBITDA Margin | -70.46% |
EBIT Margin | -70.46% |
FCF Margin | 2.98% |
Dividends & Yields
QDEL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for QDEL is $50, which is 98.7% higher than the current price. The consensus rating is "Buy".
Price Target | $50 |
Price Target Difference | 98.7% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Scores
Altman Z-Score | -0.22 |
Piotroski F-Score | 5 |